0000899243-16-022546.txt : 20160613 0000899243-16-022546.hdr.sgml : 20160613 20160613083849 ACCESSION NUMBER: 0000899243-16-022546 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160601 FILED AS OF DATE: 20160613 DATE AS OF CHANGE: 20160613 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001358762 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113651945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 BUSINESS PHONE: 972-865-2206 MAIL ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STAPLETON CRAIG R CENTRAL INDEX KEY: 0001207106 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37785 FILM NUMBER: 161709938 MAIL ADDRESS: STREET 1: 135 E. PUTNAM AVE CITY: GREENWICH STATE: CT ZIP: 06830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stapleton Pharma LLC CENTRAL INDEX KEY: 0001676901 STATE OF INCORPORATION: CT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37785 FILM NUMBER: 161709939 BUSINESS ADDRESS: STREET 1: 55 OLD FIELD POINT ROAD STREET 2: 2ND FLOOR CITY: GREENWICH STATE: CT ZIP: 06830 BUSINESS PHONE: (203) 622-1382 MAIL ADDRESS: STREET 1: 55 OLD FIELD POINT ROAD STREET 2: 2ND FLOOR CITY: GREENWICH STATE: CT ZIP: 06830 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2016-06-01 0 0001358762 REATA PHARMACEUTICALS INC RETA 0001676901 Stapleton Pharma LLC 55 OLD FIELD POINT ROAD, 2ND FLOOR GREENWICH CT 06830 0 0 1 0 0001207106 STAPLETON CRAIG R 55 OLD FIELD POINT ROAD, 2ND FLOOR GREENWICH CT 06830 0 0 1 0 Class A common stock 452864 I See Footnote Class B common stock Class A common stock 365800 I See Footnote Held of record by Stapleton Pharma LLC, a Connecticut limited liability company. Craig R. Stapleton is the sole managing member of Stapleton Pharma LLC and may be deemed to beneficially own all of the securities held of record by Stapleton Pharma LLC. However, Mr. Stapleton disclaims beneficial ownership of the issuer's securities held of record by Stapleton Pharma LLC except to the extent of his pecuniary interest therein. The Class B common stock is convertible into Class A common stock on a one-for-one basis (a) at the holder's election at any time after the date that is six months following the date of the closing of the initial public offering of the company's Class A common stock, (b) at the holder's election prior to that time subject to certain conditions, or (c) at the option of the company's board of directors, in its sole discretion, at any time or multiple times from time to time on or before the closing of the initial public offering. The conversion right of the Class B common stock has no expiration date. /s/ Craig R. Stapleton, Sole Managing Member of Stapleton Pharma LLC 2016-06-13 /s/ Craig R. Stapleton 2016-06-13